Skip to content

Herpes Simplex Virus Antibody, IgA (Serum or Plasma) – Lower Respiratory Tract Specimen

Published: August 9, 2026Updated: August 16, 2026

This test measures antibodies to the herpes simplex virus (HSV) in your respiratory tract fluids, specifically IgA antibodies. IgA is one type of antibody that helps protect mucosal surfaces, including those in the lower respiratory system.

Quick summary

["Helps identify past or current HSV infection in respiratory samples, aiding in diagnosis of conditions like pneumonia or respiratory infections caused by HSV."]

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
91833-4
Short code
HSV Ag Lower resp Ql IF
Synonyms
HSV Ag Lower resp Ql IF
Category
chemistry
Sample
serum
Container
Red-top tube (SST)
Units
N/A
Fasting
false
Population
adult
Sex
all
Age range
18–65 years
Method
if
Specimen volume
5 mL
Stability
Room temperature: 4h, Refrigerated: 24h, Frozen: 7d
Hemolysis max
500
Lipemia max
1000
Icterus max
500
TAT
4–24 hours
Order
routine

Why This Test Might Be Ordered

Your healthcare provider may recommend this test if you have symptoms like persistent cough, fever, or other respiratory issues that could be linked to HSV infection. It’s also used in research or specialized clinical settings to study HSV in respiratory samples.

What to Expect Before the Test

No special preparation is needed. You may provide a lower respiratory tract specimen (e.g., from a nasopharyngeal swab or bronchoalveolar lavage) depending on clinical context. If a blood sample is used, it’s typically drawn from a vein in your arm.

What the Test Measures

This test detects IgA antibodies against HSV, which your immune system produces in response to infection. IgA antibodies are particularly relevant in respiratory infections because they help protect the mucous membranes.

What the Results Mean

Positive results indicate the presence of IgA antibodies, suggesting past or current HSV exposure in the respiratory tract. Negative results mean no detectable IgA antibodies were found in the sample. Interpretation depends on clinical context, such as symptoms or other diagnostic findings.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

◆Associated findings1

Short name

IgA HSV Antibody (Lower Resp)

Frequently asked questions

How Does This Test Help Healthcare Providers?
This test can help confirm HSV infection in respiratory samples, especially in cases where symptoms like persistent cough or pneumonia are present. It may also guide treatment decisions or monitor immune response in research or specialized patient populations.
What Are Common Reasons for This Test?
Common reasons include evaluating unexplained respiratory symptoms, diagnosing HSV-related respiratory infections, or assessing immune response in clinical trials or research studies involving respiratory specimens.
What Should I Do If I Have Questions About My Results?
If you receive results from this test, discuss them with your healthcare provider. They can explain what the findings mean in relation to your health and next steps, such as treatment or further testing.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy